TIS 0.00% 0.0¢ tissue therapies limited

interview with sm, page-2

  1. 492 Posts.
    Program 1: Enabling technologies. This research appears to be perfectly suited to the development of a multilayered dressing that SM refers to.

    http://www.woundcrc.com/index.php?option=com_content&view=article&id=11&Itemid=11
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.